Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07RSA
|
||||
| Former ID |
DNC005914
|
||||
| Drug Name |
N-(4-phenylbenzoyl)-phenylalanyl-glycine-nitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527885] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C24H21N3O2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CC(C(=O)NCC#N)NC(=O)C2=CC=C(C=C2)C3=CC=CC=<br />C3
|
||||
| InChI |
1S/C24H21N3O2/c25-15-16-26-24(29)22(17-18-7-3-1-4-8-18)27-23(28)21-13-11-20(12-14-21)19-9-5-2-6-10-19/h1-14,22H,16-17H2,(H,26,29)(H,27,28)/t22-/m0/s1
|
||||
| InChIKey |
DWFFMEGYLGKXHE-QFIPXVFZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | Inhibitor | [527885] | |
| Cathepsin L | Target Info | Inhibitor | [527885] | ||
| Cathepsin S | Target Info | Inhibitor | [527885] | ||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.